2026 Expert Speaker Faculty

Take a look at the esteemed speaker faculty for the World Clinical Biomarkers & CDx Japan Summit.

Michel Mommejat, President Representative Director & Chief Innovation Officer, A.D.A.M. Innovations

Michel Mommejat

Vihanga Pahalawatta, Director, Device Regulatory Affairs (CDx) AbbVie

Vihanga Pahalawatta

Steven Walker, Director of Product Management, Almac Diagnostic Services

Steve Walker

Shelley Shaw - Head of Oncology Marketing, Astellas

Shelley Shaw

Takaharu Hino - Senior Director, Regulatory Strategy & Policy, Oncology, R&D, AstraZeneca

Takaharu Hino

Takaaki Miyazaki - Biomarker Expert, Bayer Yakuhin

Takaaki Miyazaki

Yukinori Ozaki - Chief Physician, Breast Medical Oncology, Cancer Institute Hospital, Japan Foundation for Cancer Research

Yukinori Ozaki

Koichi Tazaki - Senior Director, Daiichi Sankyo

Koichi Tazaki

Yuji Otsuki - Chief Executive Officer, FerreptoCure

Yuji Otsuki

Zach Boyd - Vice President, Global Head of Precision Medicine & Diagnostics, Johnson & Johnson Innovative Medicine

Zach Boyd

Min Qing - Director, Oncology Precision Medicine & Diagnostics, Johnson & Johnson Innovative Medicine

Min Qing

Valerie Mbella - Senior Director, Global Regulatory Affairs, Diagnostics Leader, Johnson & Johnson Innovative Medicine

Valerie Mbella

Flora Berisha - Executive Director, Global Head of Diagnostic Partnering & Development, Johnson & Johnson Innovative Medicine

Flora Berisha

Tomohiko Makino - Deputy Director, Ministry of Health, Labour & Welfare Japan

Tomohiko Makino

Lou Welebob - Senior Vice President of Biopharma Companion Diagnostics Myriad Genetics

Lou Welebob

Tadayoshi Hashimoto - Physician, National Cancer Center Hospital East

Tadayoshi Hashimoto

Mitsuho Imai - Medical Oncologist, National Cancer Center Hospital East

Mitsuho Imai

Ken Shimamura - Diagnostic Research & Development Lead, Pfizer

Ken Shimamura

Elnaz Jokar - Senior Manager, IVD Regulatory Affairs, Regeneron

Elnaz jokar

Philippe Menu, Executive Vice President, Chief Medical Officer & Chief Product Officer, SOPHiA GENETICS

Philippe Menu

Kazunori Yamanaka - Lead, Medical Bioinformatics & Translational Research, Takeda

Kazunori Yamanaka

Noriyuki Ohta, Manager, Audit Department, MHS Division, TUV SUD

Noriyuki Ohta

Explore the Agenda

Explore the Agenda

Hear the latest breakthroughs and technologies for biomarker and CDx development, case studies for gaining regulatory approval, and commercialisation strategies.

Partner with us

Partner With Us

Position yourself alongside other IVD, biomarker, multi-omics, and digital pathology solution providers, showcasing your capabilities to a room full of pharmaceutical leaders.

Join Biopharma Experts

Join Biopharma Experts

Unite with your fellow industry leaders and academic pioneers advancing precision medicine within Japan and globally to progress the future of streamlined CDx co-development.